Investigation of the Clinical Remission Course in Ulcerative Colitis from Tofacitinib Induction to Tapering or Withdrawal in Japanese Patients: A Single-Center Retrospective Study
Introduction: Tofacitinib (TOF), a Janus kinase inhibitor, has emerged as an innovative treatment option for patients with moderate-to-severe ulcerative colitis (UC). However, the clinical course of patients who achieve induction and maintain remission followed by TOF tapering or withdraw...
Saved in:
| Main Authors: | Miki Koroku, Teppei Omori, Shun Murasugi, Ayumi Ito, Maria Yonezawa, Shinichi Nakamura, Katsutoshi Tokushige, Yousuke Nakai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2025-01-01
|
| Series: | Inflammatory Intestinal Diseases |
| Online Access: | https://karger.com/article/doi/10.1159/000545704 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Influence of Obesity on Small Bowel Capsule Endoscopy
by: Teppei Omori, et al.
Published: (2022-01-01) -
A case of incorrect evaluation of intestinal patency by early dissolution of a patency capsule
by: Teppei Omori, et al.
Published: (2024-04-01) -
Potential predictors of efficacy outcomes following tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a post hoc analysis of outcomes from the RIVETING study
by: Joana Torres, et al.
Published: (2025-02-01) -
Discovery of Novel Tofacitinib–ADTOH Molecular Hybridization Derivatives for the Treatment of Ulcerative Colitis
by: Yi Mou, et al.
Published: (2025-03-01) -
Effect of Tofacitinib on Hemostasis in Patients with Ulcerative Colitis: A Comparative Ex Vivo Study
by: Cristina Sánchez-Sánchez, et al.
Published: (2025-04-01)